Detalhe da pesquisa
1.
Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization.
Virol J
; 14(1): 123, 2017 06 26.
Artigo
Inglês
| MEDLINE | ID: mdl-28651593
2.
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.
NPJ Vaccines
; 6(1): 39, 2021 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33741993
3.
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.
Nat Commun
; 12(1): 5877, 2021 10 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34620860
4.
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
J Exp Med
; 218(7)2021 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33909009
5.
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.
NPJ Vaccines
; 5: 91, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33083026
6.
Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice.
PLoS One
; 14(11): e0225063, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31725776
7.
Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice.
Front Immunol
; 9: 2350, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30369928
8.
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.
NPJ Vaccines
; 3: 25, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29977611